ADO and ovarian carcinoma: Low ADO concentrations reduced migration and the invasive capacity of prostate and breast cancer cell lines (287) and human cervical and ovarian cancer cell lines (288, 289), but enhanced stemness and EMT gene expression in gastric cancer cells by activation of A2AR and the Akt/mTOR pathway (290).